[논문]대면 및 비대면 한의 체중조절 프로그램에 참여한 과체중, 비만 환자에서의 체중감량 및 이상반응 비교 분석: 후향적 차트 리뷰

김은주; 임영우; 옥지명; 김서영

doi:10.13048/jkm.22031

대면 및 비대면 한의 체중조절 프로그램에 참여한 과체중, 비만 환자에서의 체중감량 및 이상반응 비교 분석: 후향적 차트 리뷰
Analysis of Weight Loss and Adverse Events in Overweight, and Obese Patients on Korean Medicine Weight Management Program with Face-to-Face Treatment and Non-Face-to-Face Treatment: A Retrospective Chart Review 원문보기

Journal of Korean Medicine = 대한한의학회지, v.43 no.3, 2022년, pp.65 - 78

김은주 (누베베 한의원 분당점) , 임영우 (누베베 한의원 분당점) , 옥지명 (누베베 한의원 강남점) , 김서영 (누베베 한의원 분당점)

Abstract ▼ AI-Helper

Objectives: The purpose of this study is to analyze the weight loss and the adverse events of overweight and obese adults on weight loss program with face-to-face treatment (FTF) and non-face-to-face treatment (NFTF) in 6 Korean Medicine obesity clinics. Methods: From March 2nd to March 10th, 2021, we collected data with a retrospective way from overweight and obese adults (body mass index, BMI≥23 kg/m2) who registered for a 12-week Gamitaeeumjowi-tang prescription program. After matching initial information of the FTF group and the NFTF group using propensity matching score, weight loss and BMI change were analyzed, and adverse events were evaluated in terms of causality, severity and system-organ classes. Results: Weight and BMI change from baseline to 12 weeks was -7.98±3.09kg (10.41±3.57%), -3.03±1.14kg/m2 and -7.30±3.11kg (9.59±3.45%), -2.76±1.15kg/m2 for FTF group and NFTF group, respectively. Body weight and BMI significantly decreased before and after treatment in both groups, and there was no significant difference in weight loss and BMI change between the two groups. No serious adverse events were reported. Conclusions: This study showed the potential that NFTF weight management treatment could be a good alternative way to FTF weight management treatment without serious adverse events.

주제어

표/그림 (8)

그림 Fig. 1. Non-face-to-face treatment protocol. NFTFT: non-face-to-face treatment
표 Table 1. Exclusion Criteria for Prescription
그림 Fig. 2. Flowchart of dataset for analysis FTFT: face-to-face treatment; NFTFT: non-face-to-face treatment; PSM: propensity score matching
표 Table 2. Basal Characteristics of Subjects
표 Table 3. Comparison of Changes in Weight and Body Mass Index
그림 Fig. 3. Weight loss and BMI change with a general linear model FTFT: face-to-face treatment; NFTFT: none face-to-face treatment Weight and body mass index were significantly decreased before and after treatment in each group (p0.05).
표 Table 4. Adverse Events Reported from 46 subjects
표 Table 5. Adverse Events According to System Organ Classes

참고문헌 (30)

World Health Organization, Telemedicine:？opportunities and developments in member？states. Report on the second global survey on？eHealth., 2010
Lee, J. (2020). The recent trends in telemedicine？in the era of COVID-19 and policy recommendations？for the balanced growth of healthcare service？industry in Korea. JCCT, 6(4), 591-598. DOI :https://doi.org/10.17703/JCCT.2020.6.4.591

원문보기 상세보기
Baek, K. (2020). A study on telemedicine in？the United States: focusing on implications for？countermeasures about COVID-19. Kyungpook？Natl. Univ. Law Journal, 70, 363-386. DOI :10.17248/knulaw..70.202007.363
Wall, K.C., Politzer, C.S., Chahla, J., Garrigues,？G.E. (2020). Obesity is associated with an？increased prevalence of glenohumeral osteoarthritis？and arthroplasty: A cohort study. Orthop Clin？N Am, 51(2), 259-264. DOI: 10.1016/j.ocl.2019.12.001

상세보기
Kolb, R., Sutterwala, F.S., Zhang, W. (2016).？Obesity and cancer: inflammation bridges the？two. Curr Opin Pharmacol, 29, 77-89. DOI:10.1016/j.coph.2016.07.005

상세보기
Zhou, Y., Chi, J., Lv, W., Wang, Y. (2021).？Obesity and diabetes as high-risk factors for？severe coronavirus disease 2019 (Covid-19).？Diabetes Metab Res Rev, 37(2), e3377.？doi:10.1002/dmrr.3377.

상세보기
Won, S., Lee, M., Moon, S., Jung, H., Ki, J.,？Park, S., et al. (2021). The necessity of analyzing？the effectiveness of temporary non-face-to-face？treatment. 2021 Analysis of National Assembly？Audit Issues, 9, 37-38.
Lee, A., Lee, D., Kim, M., Lee, H., Choi, K.,？Kim, S., et al. (2021). Gamitaeeumjowee-tang？for weight loss in diabetic patients: A？retrospective chart review. J Korean Med,？42(1), 46-58. DOI: https://doi.org/10.13048/jkm.21004

원문보기 상세보기
Kang, E., Park, Y., Kim, M., Park, Y. (2017).？A Study on Factors Associated with Weight？Loss by 'Gamitaeeumjowee-Tang'. J Korean？Med Obes Res, 17(2), 68-72. DOI : https://doi.org/10.15429/jkomor.2017.17.2.68

원문보기 상세보기
Yoon, N., Yoo, Y., Kim, M., Kim, S., Lim,？Y., Lim, H., et al. (2018). Analysis of adverse？events in weight loss program in combination？with 'Gamitaeeumjowee-tang' and low-calorie？diet. J Korean Med Obes Res, 18(1), 1-9. DOI: https://doi.org/10.15429/jkomor.2018.18.1.1

원문보기 상세보기
Park, Y., Cominguez, D., Kim, H., Jin, J.,？Koh, D., Kim, S., et al. (2021). Therapeutic？effects of Gambi-jung for the treatment of？obesity. Biomed Pharmacother, 141, 111838.？DOI: 10.1016/j.biopha.2021.111838

상세보기
Lee, E., Park, Y., Lim, Y., Kim, S. (2020).？The association between sleep and weight loss？among adult women with obesity administered？with Gamitaeeumjowee-tang. J Korean Med,？41(3), 22-31. DOI : https://doi.org/10.13048/jkm.20023

원문보기 상세보기
Korea Institute of Drug Safety & Risk Reaction？Management. Adverse Drug Assessment Report.？1st ed. Seoul: Korea Institute of Drug Safety？& Risk Management. 2013:60-3.
National Cancer Institute. National Institute of？Health. U.S. DEPARTMENT OF HEALTH？AND HUMAN SERVICES. Common Terminology？Criteria for Adverse Events (CTCAE) Version 4.0. 2010.
Korea Institute of Drug Safety & Risk？Management. Terminology Guide for Reporting？Adverse Drug Reactions. Seoul: Korea Institute？of Drug Safety & Risk Management. 2014:1-6.
Kim, E., Lim, Y., Park, Y., Kang, J., Kim, S.？(2022). Prediction of initial average weight？loss in overweight and obese people taking？Gamitaeeumjowi-tang. Korean J Subhealth？Med, 3(1), 13-22. DOI :https://doi.org/10.37928/kjsm.2022.3.1.13

상세보기
Han, J., Park, Y. (2019). Analysis of Factors？Influencing Obesity Treatment according to？Initial Condition and Compliance with？Medication. J Korean Med Obes Res, 19(1),？31-41. DOI : https://doi.org/10.15429/jkomor.2019.19.1.31

원문보기 상세보기
Choi, Y. (2020). A study on the introduction？of telemedicine -Coronavirus disease 2019 and？the need for the introduction of telemedicine-.？International law review, 12(1), 113-137. DOI: 10.36727/jjilr.12.1.202005.005
Fleischman, A., Hourigan, S.E., Lyon, H.N.,？Landry, M.G., Reynolds, J., Steltz, S.K., et al.？(2016). Creating an integrated care model for？childhood obesity: a randomized pilot study？utilizing telehealth in a community primary？care setting. Clin Obes, 6(6), 380-388. doi:10.1111/cob.12166.

상세보기
Perri, M.G., Shankar, M.N., Daniels, M.J.,？Durning, P.E., Ross, K.M., Limacher, M.C., et？al. (2020). Effect of telehealth extended care？for maintenance of weight loss in rural US？communities: a randomized clinical trial.？JAMANetwOpen, 3(6), e206764. doi: 10.1001/jamanetworkopen.2020.6764.

상세보기
Johnson, K.E., Alencar, M.K., Coakley, K.E.,？Swift, D.L., Cole, N.H., Mermier, C.M., et al.？(2019). Telemedicine-based health coaching is？effective for inducing weight loss and？improving metabolic markers. Telemed J E？Health, 25(2), 85-92. doi: 10.1089/tmj.2018.0002.

상세보기
Befort, C.A., VanWormer, J.J., Desouza, C.,？Ellerbeck, E.F., Gajewski, B., Kimminau, K.S.,？et al. (2021). Effect of behavioral therapy with？in-clinic or telephone group visits vs in-clinic？individual visits on weight loss among patients？with obesity in rural clinical practice: A？Randomized Clinical Trial. JAMA, 325(4),？363-372. DOI: 10.1001/jama.2020.25855

상세보기
Jeong, J., Jeon, J., Bae, K., Choi, Y., Park, K.,？Kim, J., et al. (2018). Smart Care Based on？Telemonitoring and Telemedicine for Type 2？Diabetes Care: Multi-Center Randomized？Controlled Trial. Telemed J E Health, 24(8),？604-613. doi: 10.1089/tmj.2017.0203

상세보기
Margolis, K.L., Asche, S.E., Bergdall, A.R.,？Dehmer, S.P., Groen, S.E., Kadrmas, H.M., et？al. (2013). Effect of home blood pressure？telemonitoring and pharmacist management on？blood pressure control: a cluster randomized？clinical trial. JAMA, 310(1), 46-56. DOI:10.1001/jama.2013.6549

상세보기
Donnelly, J.E., Goetz, J., Gibson, C., Sullivan,？D.K., Lee, R., Smith, B.K., et al. (2013).？Equivalent weight loss for weight management？programs delivered by phone and clinic.？Obesity (Silver Spring). 21(10), 1951-9. doi:10.1002/oby.20334.

상세보기
Hwang, M., Shin, H., Song, M. (2007).？Literature review of herbal medicines on？treatment of obesity since 2000;mainly about？Ephedra Herba. J Korean Med Obes Res, 7(1),？39-54.
Lee, D. (2016). An introduction to propensity？score matching methods. Anesth Pain Med, 11,？130-148. DOI: https://doi.org/10.17085/apm.2016.11.2.130

상세보기
Lee, H., Kim, Y., Park, I. (2013). Calculation？of sample size in clinical trials. Clinics？Shoulder Elbow, 16(1), 53-57. https://doi.org/10.5397/CiSE.2013.16.1.53

원문보기 상세보기
A handbook on clinical trial design and？number of subjects. Department of Applied？Statistics in National Institute of Toxicological？Research. 2008 Oct[cited 2021. Dec 27];p.35.？Available from: URL:https://www.mfds.go.kr/brd/m_218/view.do?eq8573&srchFr&srchTo&srchWordsrchTp&srchTp&itm_seq_10&itm_seq_20&multi_itm_seq0&company_cd&company_nm&page64
Pellegrini, D., Torlasco, C., Ochoa, J.E., Parati,？G. (2020). Contribution of telemedicine and？information technology to hypertension control.？Hypertens Res, 43(7), 621-628. DOI: 10.1038/s41440-020-0422-4

상세보기

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format